Filgrastim vs pegfilgrastim: A quality of life issue for children
Administration, safety, and efficacy are similar in both agents. However, the frequency of administration makes a significant difference for patients.
Pediatric Cancer
ASCO: Crizotinib tolerated, active in pediatric patients
Crizotinib active in anaplastic large cell lymphoma; neuroblastoma; other tumors with ALK mutations.
P-CAS tool updated for gauging constipation in pediatric cancer patients
Updates to the scale ensure the questions are more accurate and relevant to pediatric cancer patients.
Heterogeneity characterizes induction failure in child ALL
Pediatric patients with induction failure often present with high-risk features.
ATRX Mutation Linked With Age at Diagnosis of Neuroblastoma
Stratification by age at diagnosis shows more mutations found in children diagnosed at an older age.
Long-Term Cardiac Effects for Childhood Cancer Survivors
Cardiovascular abnormalities, markers of systemic inflammation and atherosclerotic disease seen
Siblings of cancer patients can be coached to cope
A two-session intervention might improve how well a youth adjusts to the cancer diagnosis of a brother or sister.
Beads of Courage: A linear story of a child’s bravery on the journey to recovery
Tiny works of art are stringed together to tell a child’s story of courage during the course of treatment for cancer or another serious illness.
Incentive spirometer inspires a video game that encourages recovery in pediatric patients
An incentive spirometer was the inspiration for a video game to help young cancer patients rebuild lung function.
Understanding ototoxicity risks for pediatric oncology patients
Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient’s hearing.
- Loading...
Loading...
Next post in CE Courses
Loading... 
Loading...